Search - tctmd.com

Displaying 441 - 460 of 539

Sort: Relevancy | Date

News Daily News

高灵敏度CRP可预测接受DES的患者的长期死亡率

L.A. McKeown

July 20, 2015

News Industry News

OrbusNeich Announces Enrollment of First Patient in China Recovery Study

July 20, 2015

News Daily News

Los SLF y SMD son Ambos Aptos para el Tratamiento de Pacientes con Lesiones IVS

July 20, 2015

News Daily News

La PCR de Alta Sensibilidad Predice la Mortalidad a Largo Plazo en Pacientes que recibieron SLF

L.A. McKeown

July 20, 2015

News Daily News

High-Sensitivity CRP Predicts Long-term Mortality in Patients Receiving DES

L.A. McKeown

July 20, 2015

News Daily News

DES、BMS 均适合治疗患隐静脉桥血管病变的患者

July 20, 2015

News Daily News

DES, BMS Both Suitable for Treating Patients With SVG Lesions

July 20, 2015

Presentation

Safety and Clinical Effectiveness of DES for SVG Intervention in Older Individuals

Presenter: J. Matthew Brennan

July 17, 2015

Presentation

High-Sensitivity C-Reactive Protein Predicts 10-Year Cardiovascular Outcome After PCI

Presenter: RM. Oemrawsingh

July 17, 2015

News Daily News

Un Meta Análisis Confirma que las PCI Sin Soporte Quirúrgico son Seguras

July 16, 2015

News Daily News

Meta-analysis Confirms Safety of PCI without Surgical Backup

July 16, 2015

News Daily News

Meta 分析证实 PCI 在无外科手术备选方案时同样安全

July 16, 2015

News Industry News

Hospira Announces U.S. Launch of Generic Bivalirudin for Injection

July 16, 2015

Presentation

Stroke in the TOTAL Trial: A Randomized Trial of Routine Thrombectomy vs PCI Alone in STEMI

Presenter: Sanjit S. Jolly

July 13, 2015

News Industry News

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

July 09, 2015

Advertisement

高灵敏度CRP可预测接受DES的患者的长期死亡率

OrbusNeich Announces Enrollment of First Patient in China Recovery Study

Los SLF y SMD son Ambos Aptos para el Tratamiento de Pacientes con Lesiones IVS

La PCR de Alta Sensibilidad Predice la Mortalidad a Largo Plazo en Pacientes que recibieron SLF

High-Sensitivity CRP Predicts Long-term Mortality in Patients Receiving DES

DES、BMS 均适合治疗患隐静脉桥血管病变的患者

DES, BMS Both Suitable for Treating Patients With SVG Lesions

Safety and Clinical Effectiveness of DES for SVG Intervention in Older Individuals

High-Sensitivity C-Reactive Protein Predicts 10-Year Cardiovascular Outcome After PCI

Un Meta Análisis Confirma que las PCI Sin Soporte Quirúrgico son Seguras

Meta-analysis Confirms Safety of PCI without Surgical Backup

Meta 分析证实 PCI 在无外科手术备选方案时同样安全

Hospira Announces U.S. Launch of Generic Bivalirudin for Injection

Stroke in the TOTAL Trial: A Randomized Trial of Routine Thrombectomy vs PCI Alone in STEMI

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content